LatchBio's Antibody Benchmark: Opus and Gemini Lead, OpenAI Lags
LatchBio released a 100-task Antibody Discovery Benchmark testing AI agents' scientific decisions across therapeutic antibody discovery stages, with Opus and Gemini leading while OpenAI models unexpectedly underperformed.
2026-09-03 ~ 2026-09-03 · 4 related posts
- Antibody Discovery Benchmark: 100 evals to test AI agents' scientific decisions across drug discovery — kenbwork · 2026-09-03
- LatchBio launches Antibody Discovery Benchmark: 100 evals testing AI agents' scientific decisions — kenbwork · 2026-09-03
- LatchBio's antibody discovery benchmark: Opus and Gemini lead, OpenAI models underperform — kenbwork · 2026-09-03
1 near-duplicate retellings: shensi